Motley Fool Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,871
Closed -$391K 120
2020
Q1
$391K Sell
4,871
-5
-0.1% -$518 0.03% 116
2019
Q4
$521K Buy
4,876
+322
+7% +$33.6K 0.03% 117
2019
Q3
$487K Buy
4,554
+38
+0.8% +$3.9K 0.03% 118
2019
Q2
$460K Buy
4,516
+79
+2% +$7.59K 0.03% 120
2019
Q1
$399K Buy
4,437
+1,926
+77% +$167K 0.03% 123
2018
Q4
$209K Buy
2,511
+37
+1% +$3.47K 0.02% 129
2018
Q3
$267K Buy
2,474
+44
+2% +$4.83K 0.02% 126
2018
Q2
$267K Sell
2,430
-139
-5% -$14.5K 0.02% 126
2018
Q1
$258K Sell
2,569
-129
-5% -$13.2K 0.02% 132
2017
Q4
$266K Buy
2,698
+9
+0.3% +$853 0.02% 137
2017
Q3
$252K Sell
2,689
-84
-3% -$8.92K 0.02% 136
2017
Q2
$308K Buy
2,773
+125
+5% +$13.2K 0.03% 134
2017
Q1
$260K Buy
+2,648
New +$252K 0.03% 143

Other funds holding DGX

Motley Fool Wealth Management's DGX Position: Q2 2020 in Review

Motley Fool Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 4,871 shares — an estimated $391K sold.

Motley Fool Wealth Management first reported a position in DGX in Q1 2017 and held it in 13 quarters. The position peaked at $521K in Q4 2019. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Motley Fool Wealth Management reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Motley Fool Wealth Management sold 4,871 Quest Diagnostics shares in Q2 2020, an estimated $391K.
  • Motley Fool Wealth Management first reported a position in Quest Diagnostics in Q1 2017 and held it in 13 quarters.
  • Motley Fool Wealth Management's Quest Diagnostics position peaked at $521K in Q4 2019.
  • 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Motley Fool Wealth Management's 13F filing for Q2 2020, filed 12 Aug 2020.